Section Arrow
Quote
EBS.NYSE
- Emergent BioSolutions Inc.
Quotes are at least 15-min delayed:2025/07/04 13:38 EDT
Last
 6.99
-0.12 (-1.69%)
Day High 
7.29 
Prev. Close
7.11 
1-M High
7.145 
Volume 
917.38K 
Bid
6.94
Ask
7.03
Day Low
6.88 
Open
7.2 
1-M Low
6.01 
Market Cap 
385.92M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 6.58 
20-SMA 6.5 
50-SMA 6.08 
52-W High 15.1 
52-W Low 4.02 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-2.58/3.82
Enterprise Value
1.05B
Balance Sheet
Book Value Per Share
10.18
Cash Flow
Cash Flow Yield
0.29
Income Statement
Total Revenue
1.01B
Operating Revenue Per Share
19.78
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed：2025/07/04 13:38 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segmentwhich consists of NARCAN and other commercial products.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.